Opsona Therapeutics founder receives prestigious Boyle Medal

 

Prof Luke O'Neill Awarded Prestigious Boyle Medal

 

 Dublin, Ireland - 7 October 2009

Opsona Therapeutics founder, Dr. Luke O' Neill, Professor of Biochemistry at Trinity College Dublin, has been awarded the 2009 Boyle Medal for his seminal work in elucidating signaling mechanisms of the immune system.

The Boyle medal is Ireland's premier award to recognise excellence in scientific research where the medal is presented to candidates who have made a contribution of global importance to their chosed research field.

Prof O'Neill has made groundbreaking discoveries in the area of Innate Imunity, specifically Toll-Like Receptor (TLR) signalling, in the company which he co-founded with colleagues from Trinity College in 2004.

Today, Opsona is built upon many of the discoveries which Professor O' Neill has contributed to scientifically. Opsona's lead program is an anti-TLR2 antibody and has shown very promising results in a number of preclinical studies including cardiac and kidney ischemia/reperfusion injuries and rheumatiod arthritis, and is expected to commence clinical testing in 2010.

 

For further information please contact:

Email: info@opsona.com

For media queries please contact:

Niamh Lyons
Tel + 353 1 6633602
or
Jonathan Birt
Tel + 44 20 72697205